{
  "trial_id": "NCT02328222",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "age",
      "label": "met",
      "evidence": "22yo"
    },
    {
      "criterion": "gender",
      "label": "met",
      "evidence": "F"
    },
    {
      "criterion": "PRA class I and II HLA <20%",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "living donor",
      "label": "met",
      "evidence": "Living donor"
    }
  ],
  "exclusion": [
    {
      "criterion": "co-morbidities requiring steroid use",
      "label": "not_met",
      "evidence": "otherwise healthy"
    },
    {
      "criterion": "delayed graft function or AR during 5 days post-transplantation",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "patients who decided to leave the study",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "multiorganic recipients",
      "label": "not_met",
      "evidence": ""
    }
  ],
  "notes": "Pt is a 22yo F otherwise healthy with a 5 yr history of systemic mastocytosis, presenting with flushing and tachycardia concerning for another flare. She responded well to IV steroids and was stabilized.",
  "_meta": {
    "topic_id": "10",
    "trial_id": "NCT02328222",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}